icon-folder.gif   Conference Reports for NATAP  
 
  63rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 9-12 2012		 Back grey_arrow_rt.gif
 
 
 
The Pharmacokinetic Interaction Between the Investigational NS3/4A HCV Protease Inhibitor TMC435 and Methadone
 
 
  Reported by Jules Levin
AASLD Nov 2012 Boston
 
S Ouwerkerk-Mahadevan1, M Beaumont-Mauviel1, M Peeters1, SH Akuma1, V Sekar2 1Tibotec BVBA, Belgium, 2Tibote Inc, Titusville, NJ, USA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif